RAS, wanted dead or alive: advances in targeting RAS mutant cancers
And now that the semaglutide shortage is over, you may need to switch to FDA-approved versions anyway
Nucleofections were performed with a protocol optimized for MEFs using the Neon electroporation system (Invitrogen) (cells resuspended in Gibco 1xPBS, 1350 mV, 1 pulse, 30 ms) or Amaxa nucleofection system (Lonza) with proprietary nucleofection protocols optimized for HCT116 or MEFs, and cells resuspended in Solution I (5 mM KCl, 15 mM MgCl 2 , 50 mM Mannitol, 120 mM sodium phosphate solution pH 7.2)
Whether this should be regarded as specific metabolic treatment, targeting only the metabolic alterations of the syndrome, is debatable, since the improvement in metabolic conditions, e.g., insulin resistance, would tenably have a positive impact also in gonadal function in women with PCOS
Holst, et al (2011)
this preserves the solution for multi-week handling in laboratory settings